• Je něco špatně v tomto záznamu ?

Expression of molecules of the Wnt pathway and of E-cadherin in the etiopathogenesis of human thymomas

P. Vodicka, L. Krskova, I. Odintsov, L. Krizova, E. Sedlackova, J. Schutzner, J. Zamecnik,

. 2020 ; 19 (3) : 2413-2421. [pub] 20200123

Jazyk angličtina Země Řecko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20004978

The molecular pathogenesis of thymoma remains largely unknown. It has been recently demonstrated, that activation of Wnt signaling pathway leads to increased incidence of thymoma in murine models. The present study investigated the activation of molecules of the Wnt signaling pathway in human thymoma. A total of 112 thymoma cases with complete clinical and follow-up data and 8 controls were included in the present study. Patients with thymoma and controls were examined immunohistochemically for β-catenin and E-cadherin. The mRNA expression levels of CTNNB1, CCND1, MYC, AXIN2 and CDH1 were analyzed by reverse transcription-quantitative PCR. Immunohistochemically, β-catenin and E-cadherin were overexpressed in neoplastic cells of all thymomas. In type A, B1 and non-invasive type B2 thymoma, both molecules were located in the cytoplasm, in contrast to invasive type B2 and B3 thymoma, where membranous immunopositivities were observed. mRNA expression levels of genes involved in the Wnt pathway and of E-cadherin were significantly increased in both type A and B thymoma compared with controls; increasing gradually from type B1 to B3, and with higher stage of disease. In recurrent type B thymoma, the mRNA expression of the molecules was significantly higher. Despite the activation of Wnt pathway in indolent type A thymoma, the negative feedback of the pathway was preserved by overexpression of inhibitory molecule axin2, which was not overexpressed in type B thymoma. In summary, the Wnt pathway was activated in human thymoma and may contribute to oncogenesis. Detection of molecules of the Wnt pathway may be of diagnostic and prognostic value.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20004978
003      
CZ-PrNML
005      
20200526134408.0
007      
ta
008      
200511s2020 gr f 000 0|eng||
009      
AR
024    7_
$a 10.3892/ol.2020.11343 $2 doi
035    __
$a (PubMed)32194741
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gr
100    1_
$a Vodicka, Prokop $u Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague 150 06, Czech Republic. First Department of Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague 128 08, Czech Republic.
245    10
$a Expression of molecules of the Wnt pathway and of E-cadherin in the etiopathogenesis of human thymomas / $c P. Vodicka, L. Krskova, I. Odintsov, L. Krizova, E. Sedlackova, J. Schutzner, J. Zamecnik,
520    9_
$a The molecular pathogenesis of thymoma remains largely unknown. It has been recently demonstrated, that activation of Wnt signaling pathway leads to increased incidence of thymoma in murine models. The present study investigated the activation of molecules of the Wnt signaling pathway in human thymoma. A total of 112 thymoma cases with complete clinical and follow-up data and 8 controls were included in the present study. Patients with thymoma and controls were examined immunohistochemically for β-catenin and E-cadherin. The mRNA expression levels of CTNNB1, CCND1, MYC, AXIN2 and CDH1 were analyzed by reverse transcription-quantitative PCR. Immunohistochemically, β-catenin and E-cadherin were overexpressed in neoplastic cells of all thymomas. In type A, B1 and non-invasive type B2 thymoma, both molecules were located in the cytoplasm, in contrast to invasive type B2 and B3 thymoma, where membranous immunopositivities were observed. mRNA expression levels of genes involved in the Wnt pathway and of E-cadherin were significantly increased in both type A and B thymoma compared with controls; increasing gradually from type B1 to B3, and with higher stage of disease. In recurrent type B thymoma, the mRNA expression of the molecules was significantly higher. Despite the activation of Wnt pathway in indolent type A thymoma, the negative feedback of the pathway was preserved by overexpression of inhibitory molecule axin2, which was not overexpressed in type B thymoma. In summary, the Wnt pathway was activated in human thymoma and may contribute to oncogenesis. Detection of molecules of the Wnt pathway may be of diagnostic and prognostic value.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Krskova, Lenka $u Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague 150 06, Czech Republic.
700    1_
$a Odintsov, Igor $u Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague 150 06, Czech Republic.
700    1_
$a Krizova, Ludmila $u Department of Oncology, First Faculty of Medicine, Charles University and General University Hospital, Prague 128 08, Czech Republic.
700    1_
$a Sedlackova, Eva $u Department of Oncology, First Faculty of Medicine, Charles University and General University Hospital, Prague 128 08, Czech Republic.
700    1_
$a Schutzner, Jan $u Third Department of Surgery, First Faculty of Medicine, Charles University and Motol University Hospital, Prague 150 06, Czech Republic.
700    1_
$a Zamecnik, Josef $u Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague 150 06, Czech Republic.
773    0_
$w MED00193499 $t Oncology letters $x 1792-1074 $g Roč. 19, č. 3 (2020), s. 2413-2421
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32194741 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20200526134404 $b ABA008
999    __
$a ind $b bmc $g 1523908 $s 1095033
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 19 $c 3 $d 2413-2421 $e 20200123 $i 1792-1074 $m Oncology letters $n Oncol Lett $x MED00193499
LZP    __
$a Pubmed-20200511

Najít záznam

Citační ukazatele

Možnosti archivace